Logo image of CCEP.AS

COCA-COLA EUROPACIFIC PARTNE (CCEP.AS) Stock Fundamental Analysis

Europe - AMS:CCEP - GB00BDCPN049 - Common Stock

77.2 EUR
+0.7 (+0.92%)
Last: 10/16/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CCEP. CCEP was compared to 29 industry peers in the Beverages industry. There are concerns on the financial health of CCEP while its profitability can be described as average. CCEP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CCEP had positive earnings in the past year.
In the past year CCEP had a positive cash flow from operations.
In the past 5 years CCEP has always been profitable.
CCEP had a positive operating cash flow in each of the past 5 years.
CCEP.AS Yearly Net Income VS EBIT VS OCF VS FCFCCEP.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

CCEP's Return On Assets of 4.83% is fine compared to the rest of the industry. CCEP outperforms 75.86% of its industry peers.
With a decent Return On Equity value of 19.11%, CCEP is doing good in the industry, outperforming 75.86% of the companies in the same industry.
With a decent Return On Invested Capital value of 7.78%, CCEP is doing good in the industry, outperforming 65.52% of the companies in the same industry.
CCEP had an Average Return On Invested Capital over the past 3 years of 7.84%. This is in line with the industry average of 8.16%.
Industry RankSector Rank
ROA 4.83%
ROE 19.11%
ROIC 7.78%
ROA(3y)5.14%
ROA(5y)4.27%
ROE(3y)19.29%
ROE(5y)16.02%
ROIC(3y)7.84%
ROIC(5y)6.6%
CCEP.AS Yearly ROA, ROE, ROICCCEP.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

Looking at the Profit Margin, with a value of 7.35%, CCEP is in line with its industry, outperforming 41.38% of the companies in the same industry.
CCEP's Profit Margin has declined in the last couple of years.
CCEP has a worse Operating Margin (11.13%) than 68.97% of its industry peers.
CCEP's Operating Margin has declined in the last couple of years.
CCEP has a Gross Margin of 35.20%. This is amonst the worse of the industry: CCEP underperforms 86.21% of its industry peers.
In the last couple of years the Gross Margin of CCEP has remained more or less at the same level.
Industry RankSector Rank
OM 11.13%
PM (TTM) 7.35%
GM 35.2%
OM growth 3Y1.73%
OM growth 5Y-1.57%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.58%
GM growth 5Y-1.5%
CCEP.AS Yearly Profit, Operating, Gross MarginsCCEP.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCEP is still creating some value.
The number of shares outstanding for CCEP has been increased compared to 1 year ago.
Compared to 5 years ago, CCEP has more shares outstanding
CCEP has a better debt/assets ratio than last year.
CCEP.AS Yearly Shares OutstandingCCEP.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CCEP.AS Yearly Total Debt VS Total AssetsCCEP.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

CCEP has an Altman-Z score of 2.06. This is not the best score and indicates that CCEP is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of CCEP (2.06) is comparable to the rest of the industry.
CCEP has a debt to FCF ratio of 6.04. This is a slightly negative value and a sign of low solvency as CCEP would need 6.04 years to pay back of all of its debts.
CCEP's Debt to FCF ratio of 6.04 is fine compared to the rest of the industry. CCEP outperforms 79.31% of its industry peers.
A Debt/Equity ratio of 1.26 is on the high side and indicates that CCEP has dependencies on debt financing.
With a Debt to Equity ratio value of 1.26, CCEP is not doing good in the industry: 68.97% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 6.04
Altman-Z 2.06
ROIC/WACC1.05
WACC7.41%
CCEP.AS Yearly LT Debt VS Equity VS FCFCCEP.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

CCEP has a Current Ratio of 0.83. This is a bad value and indicates that CCEP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.83, CCEP is not doing good in the industry: 72.41% of the companies in the same industry are doing better.
CCEP has a Quick Ratio of 0.83. This is a bad value and indicates that CCEP is not financially healthy enough and could expect problems in meeting its short term obligations.
CCEP has a Quick ratio (0.65) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.65
CCEP.AS Yearly Current Assets VS Current LiabilitesCCEP.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

CCEP shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.76%.
The Earnings Per Share has been growing slightly by 5.80% on average over the past years.
CCEP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.04%.
The Revenue has been growing by 11.21% on average over the past years. This is quite good.
EPS 1Y (TTM)-4.76%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%14.98%
Revenue 1Y (TTM)9.04%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%4.54%

3.2 Future

CCEP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.27% yearly.
CCEP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.63% yearly.
EPS Next Y4.41%
EPS Next 2Y6.45%
EPS Next 3Y7.23%
EPS Next 5Y9.27%
Revenue Next Year2.25%
Revenue Next 2Y2.59%
Revenue Next 3Y3.04%
Revenue Next 5Y3.63%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCEP.AS Yearly Revenue VS EstimatesCCEP.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
CCEP.AS Yearly EPS VS EstimatesCCEP.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 23.18 indicates a rather expensive valuation of CCEP.
Compared to the rest of the industry, the Price/Earnings ratio of CCEP indicates a slightly more expensive valuation: CCEP is more expensive than 62.07% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CCEP to the average of the S&P500 Index (27.31), we can say CCEP is valued inline with the index average.
A Price/Forward Earnings ratio of 17.00 indicates a rather expensive valuation of CCEP.
CCEP's Price/Forward Earnings is on the same level as the industry average.
CCEP is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.85, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.18
Fwd PE 17
CCEP.AS Price Earnings VS Forward Price EarningsCCEP.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CCEP is valued a bit more expensive than 62.07% of the companies in the same industry.
62.07% of the companies in the same industry are more expensive than CCEP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.71
EV/EBITDA 13.45
CCEP.AS Per share dataCCEP.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.25
PEG (5Y)4
EPS Next 2Y6.45%
EPS Next 3Y7.23%

3

5. Dividend

5.1 Amount

CCEP has a Yearly Dividend Yield of 2.56%.
Compared to an average industry Dividend Yield of 2.83, CCEP has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, CCEP has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.56%

5.2 History

The dividend of CCEP is nicely growing with an annual growth rate of 9.91%!
Dividend Growth(5Y)9.91%
Div Incr Years4
Div Non Decr Years4
CCEP.AS Yearly Dividends per shareCCEP.AS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CCEP pays out 60.89% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CCEP is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP60.89%
EPS Next 2Y6.45%
EPS Next 3Y7.23%
CCEP.AS Yearly Income VS Free CF VS DividendCCEP.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CCEP.AS Dividend Payout.CCEP.AS Dividend Payout, showing the Payout Ratio.CCEP.AS Dividend Payout.PayoutRetained Earnings

COCA-COLA EUROPACIFIC PARTNE

AMS:CCEP (10/16/2025, 7:00:00 PM)

77.2

+0.7 (+0.92%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners37.34%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap35.21B
Analysts77.27
Price Target86.76 (12.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.56%
Yearly Dividend1.98
Dividend Growth(5Y)9.91%
DP60.89%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.24%
PT rev (3m)3.46%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.57%
EPS NY rev (3m)-0.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.88%
Valuation
Industry RankSector Rank
PE 23.18
Fwd PE 17
P/S 1.69
P/FCF 17.71
P/OCF 12.04
P/B 4.39
P/tB N/A
EV/EBITDA 13.45
EPS(TTM)3.33
EY4.31%
EPS(NY)4.54
Fwd EY5.88%
FCF(TTM)4.36
FCFY5.65%
OCF(TTM)6.41
OCFY8.31%
SpS45.79
BVpS17.6
TBVpS-19.62
PEG (NY)5.25
PEG (5Y)4
Profitability
Industry RankSector Rank
ROA 4.83%
ROE 19.11%
ROCE 10.52%
ROIC 7.78%
ROICexc 8.57%
ROICexgc 51.16%
OM 11.13%
PM (TTM) 7.35%
GM 35.2%
FCFM 9.52%
ROA(3y)5.14%
ROA(5y)4.27%
ROE(3y)19.29%
ROE(5y)16.02%
ROIC(3y)7.84%
ROIC(5y)6.6%
ROICexc(3y)8.71%
ROICexc(5y)7.37%
ROICexgc(3y)64.53%
ROICexgc(5y)51.3%
ROCE(3y)10.42%
ROCE(5y)8.8%
ROICexcg growth 3Y8.99%
ROICexcg growth 5Y7.35%
ROICexc growth 3Y14.53%
ROICexc growth 5Y1.38%
OM growth 3Y1.73%
OM growth 5Y-1.57%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.58%
GM growth 5Y-1.5%
F-Score6
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 6.04
Debt/EBITDA 3.08
Cap/Depr 98.22%
Cap/Sales 4.49%
Interest Coverage 9.37
Cash Conversion 89.23%
Profit Quality 129.6%
Current Ratio 0.83
Quick Ratio 0.65
Altman-Z 2.06
F-Score6
WACC7.41%
ROIC/WACC1.05
Cap/Depr(3y)92.36%
Cap/Depr(5y)78.04%
Cap/Sales(3y)4.17%
Cap/Sales(5y)3.92%
Profit Quality(3y)141.19%
Profit Quality(5y)162.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.76%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%14.98%
EPS Next Y4.41%
EPS Next 2Y6.45%
EPS Next 3Y7.23%
EPS Next 5Y9.27%
Revenue 1Y (TTM)9.04%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%4.54%
Revenue Next Year2.25%
Revenue Next 2Y2.59%
Revenue Next 3Y3.04%
Revenue Next 5Y3.63%
EBIT growth 1Y2.97%
EBIT growth 3Y16.06%
EBIT growth 5Y9.46%
EBIT Next Year43.74%
EBIT Next 3Y17.22%
EBIT Next 5Y12.87%
FCF growth 1Y5.8%
FCF growth 3Y8.29%
FCF growth 5Y10.26%
OCF growth 1Y13.11%
OCF growth 3Y13.08%
OCF growth 5Y9.96%